Lobbying client

PEAR THERAPEUTICS

Prescription digital therapeutics company.

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 3 of its records are shown together here.

Filings
38
Filed by
3
Reported in-house
—
Reported by firms
$1,070,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2018 to 2023

Filings

8 filings for 2020, newest first.
Filing Filed by Amount
4th Quarter - Report
4th Quarter 2020
BLUEBIRD STRATEGIES $40,000 reported
4th Quarter - Report
4th Quarter 2020
K&L GATES, LLP $60,000 reported
3rd Quarter - Report
3rd Quarter 2020
BLUEBIRD STRATEGIES $40,000 reported
3rd Quarter - Report
3rd Quarter 2020
K&L GATES, LLP $60,000 reported
2nd Quarter - Report
2nd Quarter 2020
K&L GATES, LLP $60,000 reported
2nd Quarter - Report
2nd Quarter 2020
BLUEBIRD STRATEGIES $40,000 reported
Registration
2nd Quarter 2020
K&L GATES, LLP — reported
1st Quarter - Report
1st Quarter 2020
BLUEBIRD STRATEGIES $40,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
BLUEBIRD STRATEGIES 15 $510,000
K&L GATES, LLP 12 $480,000
FAEGRE BAKER DANIELS CONSULTING 8 $80,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 33
Medicare/Medicaid MMM 24
Budget/Appropriations BUD 5

Bills named in its filings

Bill numbers found in the filers' descriptions, most often named first.

BillCongressTimes named
H.R. 5333 116th 5
S. 3532 116th 5
S. 3791 117th 4
H.R. 7051 117th 4
S. 3552 116th 3
S. 5238 117th 1

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.